Optimal Sequencing of Treatment Options for Poor Risk mCRPC Previously Treated With Docetaxel
Clinical trial NCT03295565 · COMPLETED
Trial details
- NCT number
- NCT03295565
- Sponsor
- The Netherlands Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-07
- Primary completion
- 2020-12-16
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.